S&P 500   3,662.45 (+1.13%)
DOW   29,823.92 (+0.63%)
QQQ   304.01 (+1.47%)
AAPL   122.85 (+3.19%)
MSFT   215.90 (+0.85%)
FB   286.70 (+3.51%)
GOOGL   1,795.70 (+2.35%)
AMZN   3,222.72 (+1.73%)
TSLA   583.30 (+2.77%)
NVDA   535.00 (-0.20%)
BABA   264.19 (+0.32%)
CGC   26.70 (-7.29%)
GE   10.17 (-0.10%)
MU   67.09 (+4.68%)
AMD   92.49 (-0.18%)
T   28.82 (+0.24%)
NIO   45.94 (-9.08%)
F   9.24 (+1.76%)
ACB   10.12 (-13.36%)
NFLX   504.99 (+2.91%)
BA   213.38 (+1.27%)
GILD   61.12 (+0.74%)
DIS   149.09 (+0.73%)
S&P 500   3,662.45 (+1.13%)
DOW   29,823.92 (+0.63%)
QQQ   304.01 (+1.47%)
AAPL   122.85 (+3.19%)
MSFT   215.90 (+0.85%)
FB   286.70 (+3.51%)
GOOGL   1,795.70 (+2.35%)
AMZN   3,222.72 (+1.73%)
TSLA   583.30 (+2.77%)
NVDA   535.00 (-0.20%)
BABA   264.19 (+0.32%)
CGC   26.70 (-7.29%)
GE   10.17 (-0.10%)
MU   67.09 (+4.68%)
AMD   92.49 (-0.18%)
T   28.82 (+0.24%)
NIO   45.94 (-9.08%)
F   9.24 (+1.76%)
ACB   10.12 (-13.36%)
NFLX   504.99 (+2.91%)
BA   213.38 (+1.27%)
GILD   61.12 (+0.74%)
DIS   149.09 (+0.73%)
S&P 500   3,662.45 (+1.13%)
DOW   29,823.92 (+0.63%)
QQQ   304.01 (+1.47%)
AAPL   122.85 (+3.19%)
MSFT   215.90 (+0.85%)
FB   286.70 (+3.51%)
GOOGL   1,795.70 (+2.35%)
AMZN   3,222.72 (+1.73%)
TSLA   583.30 (+2.77%)
NVDA   535.00 (-0.20%)
BABA   264.19 (+0.32%)
CGC   26.70 (-7.29%)
GE   10.17 (-0.10%)
MU   67.09 (+4.68%)
AMD   92.49 (-0.18%)
T   28.82 (+0.24%)
NIO   45.94 (-9.08%)
F   9.24 (+1.76%)
ACB   10.12 (-13.36%)
NFLX   504.99 (+2.91%)
BA   213.38 (+1.27%)
GILD   61.12 (+0.74%)
DIS   149.09 (+0.73%)
S&P 500   3,662.45 (+1.13%)
DOW   29,823.92 (+0.63%)
QQQ   304.01 (+1.47%)
AAPL   122.85 (+3.19%)
MSFT   215.90 (+0.85%)
FB   286.70 (+3.51%)
GOOGL   1,795.70 (+2.35%)
AMZN   3,222.72 (+1.73%)
TSLA   583.30 (+2.77%)
NVDA   535.00 (-0.20%)
BABA   264.19 (+0.32%)
CGC   26.70 (-7.29%)
GE   10.17 (-0.10%)
MU   67.09 (+4.68%)
AMD   92.49 (-0.18%)
T   28.82 (+0.24%)
NIO   45.94 (-9.08%)
F   9.24 (+1.76%)
ACB   10.12 (-13.36%)
NFLX   504.99 (+2.91%)
BA   213.38 (+1.27%)
GILD   61.12 (+0.74%)
DIS   149.09 (+0.73%)
Log in
NASDAQ:CSII

Cardiovascular Systems Stock Forecast, Price & News

$34.66
+0.20 (+0.58 %)
(As of 12/1/2020 03:59 PM ET)
Add
Compare
Today's Range
$34.57
Now: $34.66
$35.43
50-Day Range
$34.49
MA: $36.44
$39.08
52-Week Range
$26.00
Now: $34.66
$55.22
Volume8,122 shs
Average Volume332,174 shs
Market Capitalization$1.39 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.3
Cardiovascular Systems, Inc., a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.
Cardiovascular Systems logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.68 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:CSII
CUSIP14161910
Phone651-259-1600
Employees779

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$236.54 million
Book Value$6.69 per share

Profitability

Net Income$-27,240,000.00

Miscellaneous

Market Cap$1.39 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$34.66
+0.20 (+0.58 %)
(As of 12/1/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for CSII and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

How has Cardiovascular Systems' stock price been impacted by COVID-19?

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CSII shares have decreased by 4.0% and is now trading at $34.85.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Cardiovascular Systems?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Cardiovascular Systems
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cardiovascular Systems?

Wall Street analysts have given Cardiovascular Systems a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cardiovascular Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Cardiovascular Systems
.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) posted its earnings results on Wednesday, November, 4th. The medical device company reported ($0.05) EPS for the quarter, topping the Zacks' consensus estimate of ($0.23) by $0.18. The medical device company earned $60.54 million during the quarter, compared to analysts' expectations of $56.27 million. Cardiovascular Systems had a negative net margin of 10.12% and a negative return on equity of 11.43%.
View Cardiovascular Systems' earnings history
.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems issued an update on its second quarter 2021 After-Hours earnings guidance on Wednesday, November, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $63-67 million, compared to the consensus revenue estimate of $66.01 million.

What price target have analysts set for CSII?

7 brokerages have issued 12-month price objectives for Cardiovascular Systems' shares. Their forecasts range from $40.00 to $48.00. On average, they anticipate Cardiovascular Systems' stock price to reach $45.57 in the next year. This suggests a possible upside of 30.8% from the stock's current price.
View analysts' price targets for Cardiovascular Systems
.

Who are some of Cardiovascular Systems' key competitors?

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), Xcel Energy (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and The Procter & Gamble (PG).

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the following people:
  • Mr. Scott Raymond Ward M.S., MS, B.Sc., Chairman, Pres & CEO (Age 60, Pay $1.17M)
  • Mr. Jeffrey S. Points, Chief Financial Officer (Age 43, Pay $507.49k)
  • Ms. Rhonda J. Robb, Chief Operating Officer (Age 52, Pay $830.22k)
  • Mr. Alexander Rosenstein, Gen. Counsel & Corp. Sec. (Age 48, Pay $523.26k)
  • Dr. Ryan D. Egeland M.D., Ph.D., Chief Medical Officer (Age 45, Pay $490.64k)
  • Mr. John E. Nielsen, VP of Investor Relations & Corp. Communications
  • Ms. Sandra M. Sedo, Chief Compliance Officer (Age 56)
  • Mr. David S. Whitescarver, VP of Corp. Devel. & Intellectual Property (Age 62)
  • Mr. Stephen J. Rempe, Chief HR Officer (Age 47)

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.99%), Champlain Investment Partners LLC (7.38%), State Street Corp (3.39%), New York State Common Retirement Fund (1.96%), ArrowMark Colorado Holdings LLC (1.38%) and Peregrine Capital Management LLC (1.15%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb and Sandra Sedo.
View institutional ownership trends for Cardiovascular Systems
.

Which major investors are selling Cardiovascular Systems stock?

CSII stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Peregrine Capital Management LLC, Sei Investments Co., First Quadrant L P CA, Victory Capital Management Inc., JPMorgan Chase & Co., AQR Capital Management LLC, and Gamco Investors INC. ET AL. Company insiders that have sold Cardiovascular Systems company stock in the last year include Alexander Rosenstein, and Sandra Sedo.
View insider buying and selling activity for Cardiovascular Systems
.

Which major investors are buying Cardiovascular Systems stock?

CSII stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Grandeur Peak Global Advisors LLC, Point72 Asset Management L.P., State Street Corp, Segall Bryant & Hamill LLC, Perkins Capital Management Inc., Millrace Asset Group Inc., and Aigen Investment Management LP. Company insiders that have bought Cardiovascular Systems stock in the last two years include Erik Paulsen, Martha Goldberg Aronson, and Rhonda J Robb.
View insider buying and selling activity for Cardiovascular Systems
.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $34.85.

How big of a company is Cardiovascular Systems?

Cardiovascular Systems has a market capitalization of $1.40 billion and generates $236.54 million in revenue each year. The medical device company earns $-27,240,000.00 in net income (profit) each year or ($0.79) on an earnings per share basis. Cardiovascular Systems employs 779 workers across the globe.

What is Cardiovascular Systems' official website?

The official website for Cardiovascular Systems is www.csi360.com.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]

This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.